1014 related articles for article (PubMed ID: 21927575)
21. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice.
Fukasawa H; Yamamoto T; Togawa A; Ohashi N; Fujigaki Y; Oda T; Uchida C; Kitagawa K; Hattori T; Suzuki S; Kitagawa M; Hishida A
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8687-92. PubMed ID: 15173588
[TBL] [Abstract][Full Text] [Related]
23. Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy.
Liu Z; Huang XR; Chen HY; Penninger JM; Lan HY
Lab Invest; 2012 May; 92(5):650-61. PubMed ID: 22330342
[TBL] [Abstract][Full Text] [Related]
24. TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis.
Xu F; Liu C; Zhou D; Zhang L
J Histochem Cytochem; 2016 Mar; 64(3):157-67. PubMed ID: 26747705
[TBL] [Abstract][Full Text] [Related]
25. Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice.
Ka SM; Yeh YC; Huang XR; Chao TK; Hung YJ; Yu CP; Lin TJ; Wu CC; Lan HY; Chen A
Diabetologia; 2012 Feb; 55(2):509-19. PubMed ID: 22086159
[TBL] [Abstract][Full Text] [Related]
26. Smad3 mediates ANG II-induced hypertensive kidney disease in mice.
Liu Z; Huang XR; Lan HY
Am J Physiol Renal Physiol; 2012 Apr; 302(8):F986-97. PubMed ID: 22237801
[TBL] [Abstract][Full Text] [Related]
27. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis.
Chung AC; Huang XR; Meng X; Lan HY
J Am Soc Nephrol; 2010 Aug; 21(8):1317-25. PubMed ID: 20488955
[TBL] [Abstract][Full Text] [Related]
28. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.
Wang M; Chen DQ; Wang MC; Chen H; Chen L; Liu D; Zhao H; Zhao YY
Phytomedicine; 2017 Dec; 36():243-253. PubMed ID: 29157821
[TBL] [Abstract][Full Text] [Related]
29. Nanosized titanium dioxide resulted in the activation of TGF-β/Smads/p38MAPK pathway in renal inflammation and fibration of mice.
Hong F; Wu N; Ge Y; Zhou Y; Shen T; Qiang Q; Zhang Q; Chen M; Wang Y; Wang L; Hong J
J Biomed Mater Res A; 2016 Jun; 104(6):1452-61. PubMed ID: 26850371
[TBL] [Abstract][Full Text] [Related]
30. HuangQi Decoction Ameliorates Renal Fibrosis via TGF-β/Smad Signaling Pathway In Vivo and In Vitro.
Zhao J; Wang L; Cao AL; Jiang MQ; Chen X; Wang Y; Wang YM; Wang H; Zhang XM; Peng W
Cell Physiol Biochem; 2016; 38(5):1761-74. PubMed ID: 27161221
[TBL] [Abstract][Full Text] [Related]
31. HBOA ameliorates CCl
Sun X; Huang X; Zhu X; Liu L; Mo S; Wang H; Wei X; Lu S; Bai F; Wang D; Lin X; Lin J
Biomed Pharmacother; 2019 Jul; 115():108901. PubMed ID: 31079002
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory smads and tgf-Beta signaling in glomerular cells.
Schiffer M; Schiffer LE; Gupta A; Shaw AS; Roberts IS; Mundel P; Böttinger EP
J Am Soc Nephrol; 2002 Nov; 13(11):2657-66. PubMed ID: 12397035
[TBL] [Abstract][Full Text] [Related]
33. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways.
Nakagawa T; Li JH; Garcia G; Mu W; Piek E; Böttinger EP; Chen Y; Zhu HJ; Kang DH; Schreiner GF; Lan HY; Johnson RJ
Kidney Int; 2004 Aug; 66(2):605-13. PubMed ID: 15253713
[TBL] [Abstract][Full Text] [Related]
34. The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential.
Chen HY; Huang XR; Wang W; Li JH; Heuchel RL; Chung AC; Lan HY
Diabetes; 2011 Feb; 60(2):590-601. PubMed ID: 20980457
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-302b mitigates renal fibrosis via inhibiting TGF-β/Smad pathway activation.
Sun M; Zhou W; Yao F; Song J; Xu Y; Deng Z; Diao H; Li S
Braz J Med Biol Res; 2021; 54(3):e9206. PubMed ID: 33503202
[TBL] [Abstract][Full Text] [Related]
36. Latent TGF-β1 protects against diabetic kidney disease via Arkadia/Smad7 signaling.
Wu W; Huang XR; You Y; Xue L; Wang XJ; Meng X; Lin X; Shen J; Yu X; Lan HY; Chen H
Int J Biol Sci; 2021; 17(13):3583-3594. PubMed ID: 34512167
[TBL] [Abstract][Full Text] [Related]
37. Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7.
Wang W; Huang XR; Li AG; Liu F; Li JH; Truong LD; Wang XJ; Lan HY
J Am Soc Nephrol; 2005 May; 16(5):1371-83. PubMed ID: 15788474
[TBL] [Abstract][Full Text] [Related]
38. Synovial and pulmonary dysfunctions are induced by crosstalk of Smad and Erk pathways in an arthritis model.
Lei W; Jian L; Chuanbing H; Xi C; Lei L; Tianyang L; Yao G; Haixia F; Lei Z; Zhneg L
Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):15-22. PubMed ID: 32415922
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-β and Smads.
Lan HY; Chung ACK
Contrib Nephrol; 2011; 170():75-82. PubMed ID: 21659760
[TBL] [Abstract][Full Text] [Related]
40. Ureic clearance granule, alleviates renal dysfunction and tubulointerstitial fibrosis by promoting extracellular matrix degradation in renal failure rats, compared with enalapril.
Huang YR; Wei QX; Wan YG; Sun W; Mao ZM; Chen HL; Meng XJ; Shi XM; Tu Y; Zhu Q
J Ethnopharmacol; 2014 Sep; 155(3):1541-52. PubMed ID: 25087615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
